40
Participants
Start Date
August 3, 2020
Primary Completion Date
March 5, 2021
Study Completion Date
Pozelimab
Single subcutaneous (SC) injection
Regeneron Study Site, Antwerp
Regeneron Pharmaceuticals
INDUSTRY